• 1. Fe3O4@SiO2 core–shell nanoparticles for biomedical purposes: adverse effects on blood cells?
  C. Achilli,G. F. Guidetti,A. Ciana,D. Capsoni,G. Minetti Biomater. Sci., 2016,4, 1417-1421
• 2. Evolution of cellulose into flexible conductive green electronics: a smart strategy to fabricate sustainable electrodes for supercapacitors
  Tengfei Yu,Yuehan Wu,Wei Li,Bin Li RSC Adv., 2014,4, 34134-34143
• 3. Excitonic and vibrational coherence in artificial photosynthetic systems studied by negative-time ultrafast laser spectroscopy
  Dongjia Han,Bing Xue,Juan Du,Tomohiro Miyatake,Hitoshi Tamiaki,Xin Xing,Wei Yuan,Yanyan Li Phys. Chem. Chem. Phys., 2016,18, 24252-24260
• 4. Evolving better nanoparticles: Genetic algorithms for optimising cluster geometries
  Dalton Trans., 2003, 4193-4207
• 5. Emerging themes in soft matter: responsive and active soft materials
  Julia M. Yeomans Soft Matter, 2010,6, 703-704

• Solvents and Organic Chemicals Organic Compounds Benzenoids Benzene and substituted derivatives Biphenyls and derivatives

[1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester (CAS No. 1262009-33-5): A Comprehensive Overview

[1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester (CAS No. 1262009-33-5) is a highly specialized compound with a unique molecular structure and a wide range of potential applications in the fields of medicinal chemistry and materials science. This compound is characterized by its biphenyl core, fluorine substitution, and trifluoromethyl group, which collectively contribute to its distinctive chemical properties and biological activities.

The biphenyl core is a common structural motif in many bioactive molecules and pharmaceuticals. It provides a rigid framework that can enhance the stability and binding affinity of the compound to target receptors. The presence of the fluorine atom at the 6' position and the trifluoromethyl group at the 5 position introduces significant electronic and steric effects, which can modulate the compound's reactivity and biological activity. Additionally, the 3'-methyl ester group adds further complexity to the molecule, influencing its solubility and metabolic stability.

Recent research has highlighted the potential of [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester in various therapeutic areas. For instance, studies have shown that compounds with similar structures exhibit potent anti-inflammatory and anti-cancer properties. The fluorine and trifluoromethyl groups are known to enhance lipophilicity and improve cellular uptake, making this compound a promising candidate for drug development.

In the context of medicinal chemistry, [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester has been investigated for its potential as a lead compound in the design of novel drugs. Its unique structure allows for fine-tuning of pharmacological properties through structural modifications. For example, substituting different functional groups at various positions on the biphenyl core can alter the compound's selectivity and potency towards specific targets.

Moreover, this compound has shown promise in materials science applications. The combination of its rigid biphenyl core and functional groups makes it suitable for use in organic electronics and photovoltaic devices. The high electron-withdrawing nature of the trifluoromethyl group can enhance charge transport properties, while the fluorine substitution can improve thermal stability and mechanical strength.

The synthesis of [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester involves several well-established chemical reactions. One common approach is to start with a suitable biphenyl derivative and introduce the necessary functional groups through stepwise reactions such as Suzuki coupling for the biphenyl formation, followed by selective fluorination and esterification steps. These synthetic methods are highly reproducible and can be scaled up for industrial production.

In terms of safety and handling, it is important to note that while [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester is not classified as a hazardous material under current regulations, standard laboratory safety protocols should be followed when handling this compound. Proper personal protective equipment (PPE) such as gloves and goggles should be worn to prevent skin contact and inhalation.

Future research on [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester is likely to focus on optimizing its pharmacological properties for specific therapeutic applications. Additionally, exploring its potential in advanced materials science could lead to new innovations in organic electronics and renewable energy technologies.

In conclusion, [1,1'-Biphenyl]-3,3'-dicarboxylic acid, 6'-fluoro-5-(trifluoromethyl)-, 3'-methyl ester (CAS No. 1262009-33-5) is a versatile compound with significant potential in both medicinal chemistry and materials science. Its unique molecular structure offers a foundation for further research and development across multiple disciplines.

• 1261994-91-5(3-(2-Fluoro-4-methoxycarbonylphenyl)-5-trifluoromethylbenzoic acid)
• 1261908-30-8(3-(3-Fluoro-4-methoxycarbonylphenyl)-5-trifluoromethylbenzoic acid)
• 1261585-16-3(4-Fluoro-4'-(trifluoromethyl)biphenyl-3-carboxylic acid methyl ester)
• 1261806-59-0(3-Fluoro-3'-(trifluoromethyl)biphenyl-4-carboxylic acid methyl ester)
• 1365273-05-7(Methyl 4-2-fluoro-3-(trifluoromethyl)phenylbenzoate)
• 1261912-59-7(3-(4-Fluoro-3-methoxycarbonylphenyl)-5-trifluoromethylbenzoic acid)
• 1261593-46-7(6-Fluoro-4'-(trifluoromethyl)biphenyl-3-carboxylic acid ethyl ester)
• 1261480-10-7(6-Fluoro-3'-(trifluoromethyl)biphenyl-3-carboxylic acid ethyl ester)
• 1261872-12-1(2-Fluoro-3'-(trifluoromethyl)biphenyl-4-carboxylic acid methyl ester)
• 1365271-42-6(Methyl 4-4-fluoro-3-(trifluoromethyl)phenylbenzoate)